Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Tetra Bio Pharma Inc TBPMQ

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to... see more

GREY:TBPMQ - Post Discussion

Tetra Bio Pharma Inc > Still in second place for Health Canada review
View:
Post by NSX001 on Oct 16, 2022 12:21pm

Still in second place for Health Canada review

We've been stuck at the second row of this Health Canada's "Product Submissions Under Review" sites now for over year and a half now. What is going on with Health Canada?


This is not just a delay due to Covid labour shortage. This is something else.
Can Tetra please tell their shareholders what's going on?

Are they even in contact with them?
Or are they just sitting on their laureles and doing nothing. Just what is it they do all day long in those offices to earn their money.

Please spend some of your precious time by putting pen to paper and give us an update. Make it look like your doing something for F***k sakes.

NSX001

Drug and Health Product Submissions Under Review (SUR): New drug submissions under review

 
 
         
         
         
         
         
         
         
         
         
         
 
Date modified:
 
 
 
 
 
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities
USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse